Healthcare Reimbursement Firm MSP Recovery To Be Taken Public In A US$32.6 Billion SPAC Merger

Health insurance reimbursement platform MSP Recovery (Nasdaq: MSPR) closed its business combination with special purpose acquisition company Lionheart Acquisition Corporation II on Monday. The transaction valued the combined company at an enterprise value of US$32.6 billion.

“The closing of this business combination is proof of the confidence in the strength of our business strategy and effectiveness of our innovative approach,” said MSP Recovery founder and CEO John Ruiz.

Following the closing of the transaction, the SPAC, now operating as MSP Recovery, started trading on the Nasdaq Global Market under the symbol “MSPR”. Corollary, the firm’s warrants also changes its symbol to “MSPRZ”.

The healthcare platform claims to be a “leader” in payer reimbursement recovery field for Medicare, Medicaid, commercial, and secondary health insurances.

The black check firm, on the other hand, completed its US$200 million IPO in August 2020. According to its prospectus, it intended to focus its search for target firms in the “proptech” industry–utilizing technology in dealing with real estate properties.

MSP Recovery last traded at US$3.73 on the Nasdaq.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Eldorado Gold: The $3.8 Billion Foran Mining Acquisition

Silver Tiger’s $2.35B Silver Blueprint: Two Mines, One Perfect Metals Market

Gold Is At Records. Barrick Mining Is Printing Cash. The Stock Still Fell. | Q4 Earnings

Recommended

Canadian Copper Plans 2,500 Metre Drill Program For 2026

Mercado Receives Permits For Planned 3,000 Metre Drill Program At Copalito

Related News

Oncology Firm Erasca Eyes US$300 Million IPO

Precision oncology company Erasca Inc. (NASDAQ: ERAS) began trading on the Nasdaq Global Select Market...

Friday, July 16, 2021, 11:20:00 AM

Biotech Firm OKYO Pharma Closes US$2.5 Million IPO

Biotech firm OKYO Pharma Limited (Nasdaq: OKYO) closed on Thursday its initial public offering on...

Saturday, May 21, 2022, 05:12:00 PM

Ceres Acquisition Corp To Acquire Parallel In US$1.84 Billion Transaction

Ceres Acquisition Corp (NEO: CERE.u), a special purpose acquisition corp, or SPAC, has entered into...

Monday, February 22, 2021, 07:20:24 AM

Squarepace: The IPO Deep Dive

If you’re a business looking to have an online presence, you might have tried creating...

Tuesday, May 18, 2021, 01:30:00 PM

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM